DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Clinofibrate
Clinofibrate
Clinofibrate Improved Canine Lipid Metabolism in Some but Not All Breeds
Effects of Clofibrate Derivatives on Hyperlipidemia Induced by a Cholesterol-Free, High-Fructose Diet in Rats
(12) United States Patent (10) Patent No.: US 7,795,310 B2 Lee Et Al
Metabolic Enzyme/Protease
(12) United States Patent (10) Patent No.: US 6,264,960 B1 Robins Et Al
2 12/ 35 74Al
(12) Patent Application Publication (10) Pub. No.: US 2008/0058292 A1 Tawakol (43) Pub
Review J Atheroscler Thromb, 2019; 26: 389-402
Trends in Lipid-Modifying Agent Use in 83 Countries
(12) Patent Application Publication (10) Pub. No.: US 2006/0211752 A1 Kohn Et Al
Clinical Applications of a Novel Selective Pparα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases
GSK3B Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties and Is a Novel Drug Target for Triple-Negative Breast Cancer
Accessibility Improving Information Using Online Patient Drug Reviews
United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
Report on the Deliberation Results June 13, 2017 Pharmaceutical
Improving Information Accessibility Using Online Patient Drug Reviews
(12) Patent Application Publication (10) Pub. No.: US 2006/0160867 A1 Freedman (43) Pub
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Top View
Drug Repurposing Compound Library Plus (96-Well)
Trends in Lipid-Modifying Agent Use in 83 Countries
Pharmaceutical Appendix to the Tariff Schedule 2
Drug Repurposing Compound Library (96-Well)
(12) United States Patent (10) Patent No.: US 6,638,969 B1 Keller Et Al
ICD-10-CM Table of Drugs 2019
Report on Investigation Results
Chronic Kidney Disease As a Metabolic Syndrome with Malnutrition—Need for Strict Control of Risk Factors
1246 Cardiovascular Drugs
WO 2019/030575 Al 14 February 2019 (14.02.2019) W !P O PCT
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri